These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34417872)

  • 1. ASL expression in ALDH1A1
    Lerner S; Eilam R; Adler L; Baruteau J; Kreiser T; Tsoory M; Brandis A; Mehlman T; Ryten M; Botia JA; Ruiz SG; Garcia AC; Dionisi-Vici C; Ranucci G; Spada M; Mazkereth R; McCarter R; Izem R; Balmat TJ; Richesson R; ; Gazit E; Nagamani SCS; Erez A
    Hum Genet; 2021 Oct; 140(10):1471-1485. PubMed ID: 34417872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.
    Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H
    J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice.
    Ninkina N; Tarasova TV; Chaprov KD; Roman AY; Kukharsky MS; Kolik LG; Ovchinnikov R; Ustyugov AA; Durnev AD; Buchman VL
    Neurobiol Aging; 2020 Jul; 91():76-87. PubMed ID: 32224067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Connectivity and Functionality of Aldehyde Dehydrogenase 1a1-Positive Nigrostriatal Dopaminergic Neurons in Motor Learning.
    Wu J; Kung J; Dong J; Chang L; Xie C; Habib A; Hawes S; Yang N; Chen V; Liu Z; Evans R; Liang B; Sun L; Ding J; Yu J; Saez-Atienzar S; Tang B; Khaliq Z; Lin DT; Le W; Cai H
    Cell Rep; 2019 Jul; 28(5):1167-1181.e7. PubMed ID: 31365862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson's Disease.
    Carmichael K; Evans RC; Lopez E; Sun L; Kumar M; Ding J; Khaliq ZM; Cai H
    Front Neural Circuits; 2021; 15():644776. PubMed ID: 34079441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease.
    Rangasamy SB; Dasarathi S; Pahan P; Jana M; Pahan K
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):173-187. PubMed ID: 30187283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASL Metabolically Regulates Tyrosine Hydroxylase in the Nucleus Locus Coeruleus.
    Lerner S; Anderzhanova E; Verbitsky S; Eilam R; Kuperman Y; Tsoory M; Kuznetsov Y; Brandis A; Mehlman T; Mazkereth R; ; McCarter R; Segal M; Nagamani SCS; Chen A; Erez A
    Cell Rep; 2019 Nov; 29(8):2144-2153.e7. PubMed ID: 31747589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOPAnization of tyrosine in α-synuclein by tyrosine hydroxylase leads to the formation of oligomers.
    Jin M; Matsumoto S; Ayaki T; Yamakado H; Taguchi T; Togawa N; Konno A; Hirai H; Nakajima H; Komai S; Ishida R; Chiba S; Takahashi R; Takao T; Hirotsune S
    Nat Commun; 2022 Nov; 13(1):6880. PubMed ID: 36371400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
    Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
    Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
    Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
    Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
    Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
    Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
    Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
    Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.
    Acosta SA; Tajiri N; de la Pena I; Bastawrous M; Sanberg PR; Kaneko Y; Borlongan CV
    J Cell Physiol; 2015 May; 230(5):1024-32. PubMed ID: 25251017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
    Wang X; Yang HA; Wang XN; Du YF
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.